8-KLeadership ChangesOther EventsExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Executive Changes (Jan 23, 2015)

Filed January 23, 2015For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) announced significant leadership transitions through an 8-K filing dated January 23, 2015. The key development is the retirement of Lamberto Andreotti as Chief Executive Officer, effective May 5, 2015. He will transition to an Executive Chairman role and later Non-Executive Chairman. The company has appointed Giovanni Caforio, M.D., currently Chief Operating Officer, to succeed Mr. Andreotti as CEO. This leadership change marks a pivotal moment for BMY, with Dr. Caforio, who has a strong background in commercial and operational roles within the company, set to lead the organization. The filing also notes the departure of James M. Cornelius from the Board of Directors and the election of Togo D. West, Jr. as Lead Independent Director. Investors should monitor how this new leadership shapes the company's strategic direction and execution.

Key Highlights

  • 1Lamberto Andreotti to retire as CEO effective May 5, 2015, transitioning to Executive Chairman and later Non-Executive Chairman.
  • 2Giovanni Caforio, M.D., current COO, appointed as the new CEO, effective May 5, 2015.
  • 3James M. Cornelius will not stand for re-election to the Board of Directors.
  • 4Togo D. West, Jr. elected as Lead Independent Director, effective when Andreotti assumes Chairman role.
  • 5The press release detailing these changes is attached as Exhibit 99.1.
  • 6Dr. Caforio's compensation arrangements are to be determined at a later date.
  • 7No prior arrangements or related party transactions between Dr. Caforio and the company were disclosed in relation to his CEO appointment.

Frequently Asked Questions

Giovanni Caforio, M.D., the current Chief Operating Officer, has been designated as the new Chief Executive Officer, effective May 5, 2015.

Lamberto Andreotti will remain an officer for a transition period until August 3, 2015. He will become Executive Chairman of the Board effective May 5, 2015, and Non-Executive Chairman of the Board effective August 3, 2015.

Yes, James M. Cornelius will not stand for re-election to the Board of Directors. Additionally, Togo D. West, Jr. has been elected as the Lead Independent Director.

The primary changes, including the CEO transition and Mr. Andreotti's move to Executive Chairman, are effective May 5, 2015. Mr. Andreotti's transition to Non-Executive Chairman and his officer role conclude on August 3, 2015.